GREEN BAY, Wis.—Shopko announced Wednesday that it has filed voluntary petitions for a court-supervised financial restructuring under Chapter 11 of the U.S. Bankruptcy Code. As part of the restructuring process, the company said it will conduct another major round of store closings across its various store formats. At the same time, the company said it […]
DALLAS—Eyecare Services Partners (ESP), a leader in integrated eyecare services, has appointed Susan Ludwick as senior vice president of optical services. Ludwick brings more than 25 years of optical industry leadership experience to ESP, most recently as senior vice president and brand manager of Refac Optical Group, which operates U.S. Vision Inc., the sixth-largest retail […]
NEW YORK—Natural Ophthalmics, Inc. has appointed Linda Axelrod as their new president, according to an announcement from the company. Axelrod has been with the company for 15 years and has become a familiar face at conferences and symposia across the country.
MADISON, Wis.—Rev360, a practice software and business services company for ECPs, began the new year with a new chief executive officer. Longtime health care IT executive Scott Filion assumed the title from company founder Scott Jens, OD, FAAO, at the beginning of this month. The challenge for Filion, who had joined Rev360 in September 2018 […]
PALO ALTO, Calif.—SightGlass Vision, Inc. has announced that CYPRESS, a clinical trial to control nearsightedness in children, is now enrolling patients in the U.S. and Canada. This CYPRESS study will evaluate the safety and efficacy of SightGlass Vision’s novel lenses compared to standard lenses to reduce the rate of progression of myopia in children between […]
NEW YORK—The speaker roster is expanding for the upcoming Vision Monday Global Leadership Summit, "Decoding the Consumer: The New Science of Customer Behavior." Experts in new retail and health care technologies have joined the day-long exclusive program, which will be held here on March 20 at The Times Center. In the emerging category of using […]
EMERYVILLE, Calif.—NovaBay Pharmaceuticals Inc. (NYSE American: NBY), a biopharma company that commercializes prescription Avenova for the domestic eyecare market, reported last week that its 2018 net sales are expected to be $12.6 million to $12.7 million. The company also said it expects 2019 net sales to be approximately $16 million to $16.5 million, which would […]